XTL BIOPHARMACEUTICALS LTD. Increase Decrease Through Business Combinations Deferred Tax Liability Asset
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Increase Decrease Through Business Combinations Deferred Tax Liability Asset of -$349.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes › Income Taxes
ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset · last filed 2025-04-30
| Period end | Increase Decrease Through Business Combinations Deferred Tax Liability Asset 12 month |
|---|---|
| 2024-12-31 | -$349.00K 20-F · filed 2025-04-30 |